DPP4 and type 2 diabetes mellitus: Previous cohort studies on individuals with type 2 diabetes have linked treatment with DPP-4 inhibitors (DPP-4i) to various cancers including thyroid tumors, pancreatic cancer, and cholangiocarcinoma [32–34].